Sodium 4-aminosalicylate dihydrate
 OpenBabel02212023462D

 14 11  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2393    0.0000    0.0000 Na  0  3  0  0  0 15  0  0  0  0  0  0
   -0.1299   -1.6500    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1299   -2.4750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5846   -2.8875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5846   -3.7125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2990   -4.1250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1299   -4.1250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8444   -3.7125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8444   -2.8875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1299   -4.9500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5846   -5.3625    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8444   -5.3625    0.0000 O   0  5  0  0  0  0  0  0  0  0  0  0
    3.5383   -3.7500    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  4 10  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  6  8  2  0  0  0  0
  8  9  1  0  0  0  0
  8 11  1  0  0  0  0
  9 10  2  0  0  0  0
 11 12  2  0  0  0  0
 11 13  1  0  0  0  0
M  CHG  2   2   1  13  -1
M  END
>  <CdId>
90

>  <Mol Weight>
211.1478

>  <Formula>
C7H10NNaO5

>  <ID>
T0020

>  <Name>
Sodium 4-aminosalicylate dihydrate

>  <Synonyms>
4-Amino-salicylic acid sodium salt

>  <CAS>
6018-19-5

>  <Approved status>
FDA

>  <Disease>
Respiratory system

>  <Indication>
Extrapulmonary Tubereulosis

>  <Pathways>
NF-¦ªb; oxidation-reduction

>  <Target>
Free radical scavengers inhibitor; NF-¦ÊB inhibitor

>  <Receptor>
Free radical scavengers; NF-¦ÊB

$$$$
